General Information of Drug-Metabolizing Enzyme (DME ID: DME0503)
DME Name Lactate dehydrogenase C (LDHC), Homo sapiens DME Info
UniProt ID
LDHC_HUMAN
EC Number    EC: 1.1.1.27     (Click to Show/Hide the Complete EC Tree)
Oxidoreductase
CH-OH donor oxidoreductase
NAD/NADP oxidoreductase
EC: 1.1.1.27
Lineage    Species: Homo sapiens     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Interactome
Disease Specific Interactions between Host Protein and DME (HOSPPI)
      ICD Disease Classification 02 Neoplasms
               ICD-11: 2A00 Brain cancer Click to Show/Hide the Full List of HOSPPI:        4 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Medulloblastoma Moderate hypomethylation
Interaction Name DNMT-LDHC interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 2.96E-58; delta-beta: -2.84E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the LDHC gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Lactate dehydrogenase C. As a result, the interaction between DNMT and LDHC can moderatly affect the drug-metabolizing process of Lactate dehydrogenase C.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
                            DNA methyltransferase (DNMT) Brain neuroblastoma Significant hypomethylation
Interaction Name DNMT-LDHC interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 2.81E-12; delta-beta: -4.95E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the LDHC gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Lactate dehydrogenase C. As a result, the interaction between DNMT and LDHC can significantly affect the drug-metabolizing process of Lactate dehydrogenase C.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
                            DNA methyltransferase (DNMT) Melanocytoma Moderate hypomethylation
Interaction Name DNMT-LDHC interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 3.87E-04; delta-beta: -2.64E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the LDHC gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Lactate dehydrogenase C. As a result, the interaction between DNMT and LDHC can moderatly affect the drug-metabolizing process of Lactate dehydrogenase C.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
                            DNA methyltransferase (DNMT) Peripheral neuroectodermal tumour Moderate hypomethylation
Interaction Name DNMT-LDHC interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 1.18E-06; delta-beta: -2.93E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the LDHC gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Lactate dehydrogenase C. As a result, the interaction between DNMT and LDHC can moderatly affect the drug-metabolizing process of Lactate dehydrogenase C.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2B60 Squamous cell carcinoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Squamous cell carcinoma Moderate hypomethylation
Interaction Name DNMT-LDHC interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 1.01E-03; delta-beta: -2.20E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the LDHC gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Lactate dehydrogenase C. As a result, the interaction between DNMT and LDHC can moderatly affect the drug-metabolizing process of Lactate dehydrogenase C.
The Methylation Level of Disease Section Compare with the Adjacent Tissue Moderate hypomethylation
p-value: 2.66E-02; delta-beta: -2.77E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the LDHC gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Lactate dehydrogenase C. As a result, the interaction between DNMT and LDHC can moderatly affect the drug-metabolizing process of Lactate dehydrogenase C.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2C30 Melanoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Melanoma Significant hypomethylation
Interaction Name DNMT-LDHC interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 1.81E-03; delta-beta: -3.91E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the LDHC gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Lactate dehydrogenase C. As a result, the interaction between DNMT and LDHC can significantly affect the drug-metabolizing process of Lactate dehydrogenase C.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.